Evaluation of Tau, amyloid beta, dynorphin levels and number of biochemical variables in covid-19 patients

Abstract

The study aimed to determine the levels of Tau,amyloid beta, dynorphin, and number of biochemical variables in men with COVID-19. The study groups included 30 men with COVID-19, 30 men who recovered from COVID -19, and 30 healthy men as a control group. Protein and biochemical assays include: tau, amyloid beta, dynorphin, zinc, triglycerides, HDL-C, VLDL-C and cholesterol. The results were a significant increase (P 0.05) in the levels of amyloid beta, dynorphin, HDL-C, cholesterol and LDL-C in patients. Those infected with COVID-19 compared to the control group, while in the recovery group, amyloid beta was low compared to the control group, while zinc and lipid profile were high in the recovered. While tau protein, zinc, triglycerides and VLDL-C showed a significant decrease at (P≤ 0.05) in the affected men group compared to the control group.